JESSICA GOMEZ: Open Payments
NPI 1114582681 · YORBA LINDA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 20 payments from 6 companies in 2025. Trend: 2023 $1,054 · 2024 $842 · 2025 $494
Food & beverage: $494
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $283 |
| UCB, Inc. | 3 | $86 |
| GENZYME CORPORATION | 2 | $63 |
| Janssen Biotech, Inc. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: RINVOQ, Bimzelx, DUPIXENT, SKYRIZI, TREMFYA, COSENTYX, NUCALA.
Industry payments across CA — which companies pay providers there.
